Skip to main content
SpringerLink
Log in

Tumour Suppressor Genes in Hodgkin’s Disease

  • Chapter
Etiology of Hodgkin’s Disease

Part of the book series: NATO ASI Series ((NSSA,volume 280))

  • 54 Accesses

Abstract

Molecular studies of neoplastic transformation are uncovering a process involving an accumulation of genetic alterations in the initiation and progression of neoplasia. These include oncogene activation leading to growth promotion, and the inactivation of the so-called tumour suppressor genes (TSG) resulting in loss of the growth suppressor effect.

This work was made possible by grants 92/0721 and 93/0016, from the Fondo de Investigacion Sanitaria (FIS), Spain.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahuja HG, Jat PS, Foti A, Bar-Eli M, Cline MJ (1991) Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 78:3259

    PubMed  CAS  Google Scholar 

  • Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, Dalla-Favera R (1993) Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Blood 81:166

    PubMed  CAS  Google Scholar 

  • Bandara LR, Adamczewski JP, Hunt T, La Thangue NB (1991) Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352:249

    Article  PubMed  CAS  Google Scholar 

  • Barak Y, Oren M (1992) Enhanced binding of a 95 kd protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J 11:2115

    PubMed  CAS  Google Scholar 

  • Barak Y, Juven T, Haffner R, Oren M (1993) MDM2 expression is induced by wild type p53 activity. EMBO J 12:461

    PubMed  CAS  Google Scholar 

  • Berberich SM, Cole M (1994) The mdm-2 oncogene is translocated and overexpressed in a murine plasmocytoma cell line expressing wild-type p53. Oncogene 9:1469

    PubMed  CAS  Google Scholar 

  • Barnes DM, Hanby AM, Gillett CE, Mohammed S, Hodgson S, Bobrow LG, Leigh IM, Purkis T, MacGeoch C, Spurr NK, Bartek J, Vojtesek B, Picksley SM, Lane DP (1992) Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 340:259

    Article  PubMed  CAS  Google Scholar 

  • Bartek J, Iggo R, Gannon J, Lane DP (1990) Genetic and immunohistochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893

    PubMed  CAS  Google Scholar 

  • Bennett WP, Hollstein MC, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP, Harris CC (1991) Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 6:1779

    PubMed  CAS  Google Scholar 

  • Brookstein R, Shew JY, Chen PL, Scully P, Lee WH (1990) Suppression of tumourigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712

    Article  Google Scholar 

  • Buchkovich K, Duffy LA, Harlow E (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097

    Article  PubMed  CAS  Google Scholar 

  • Bueso-Ramos CE, Yang Y, de-Leon E, McCown P, Stass SA, Albitar M (1993) The human MDM2 oncogene is overexpressed in leukemias. Blood 82:2617

    PubMed  CAS  Google Scholar 

  • Cahilly-Snyder L, Yang-Feng T, Francke U, George DL (1987) Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet 13:235

    Article  PubMed  CAS  Google Scholar 

  • Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C (1990) Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457

    Article  PubMed  CAS  Google Scholar 

  • Cesarman E, Inghirami G, Chadburn A, Knowles DM (1993) High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 143:845

    PubMed  CAS  Google Scholar 

  • Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM (1992) Structural and functional analysis of oncogenes and tumour suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood 80:3205

    PubMed  CAS  Google Scholar 

  • Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, te Riele H (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359:328

    Article  PubMed  CAS  Google Scholar 

  • Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH (1992) Clonal p53 mutation in primary cervical cancer: association with human papillomavirus negative tumours. Lancet 339:1070

    Article  PubMed  CAS  Google Scholar 

  • Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053

    Article  PubMed  CAS  Google Scholar 

  • Chen PL, Scully P, Shew JY, Wang JY, Lee WH (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193

    Article  PubMed  CAS  Google Scholar 

  • Doussis IA, Pezzella F, Lane DP, Garter KC, Mason DY (1993) An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin’s disease. Am J Clin Pathol 99:663

    PubMed  CAS  Google Scholar 

  • El-Diery WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumour suppression. Cell 75:817

    Article  Google Scholar 

  • Fakharzadeh SS, Trusko SP, George DL (1991) Tumourigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line. EMBO J 10:1565

    PubMed  CAS  Google Scholar 

  • Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T (1991) p53 is frequently mutated in Burkitt’s lymphoma cell lines. EMBO J 10:2879

    PubMed  CAS  Google Scholar 

  • Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumourigenesis. Cell 61:759

    Article  PubMed  CAS  Google Scholar 

  • Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, Goldman J, Zaccaria A, Berrebi A, Canaani E (1991) p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci USA 88:6293

    Article  PubMed  CAS  Google Scholar 

  • Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai JL, Vanrumbeke M, Loucheux-lefebvre MH, Bauters F, Berger R, Kerckaert JP (1992) Mutations of the p53 gene in B-cell Lymphoblastic Acute Leukemia: a report on 60 cases. Leukemia 6:42

    PubMed  CAS  Google Scholar 

  • Fenaux P, Collyn d’Hooghe M, Jonveaux P, Lai JL, Bauters F, Loucheux MH, Kerckaert JP (1990) Rearrangement and expression of the p53 gene in myelodysplasia syndrome and acute leukemia. Nouv Rev Fr Hematol 32:341

    PubMed  CAS  Google Scholar 

  • Finlay CA (1993) The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol Cell Biol 13:301

    PubMed  CAS  Google Scholar 

  • Finlay CA, Hinds PW, Levine AJ (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083

    Article  PubMed  CAS  Google Scholar 

  • Friend SH, Bernardos R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643

    Article  PubMed  CAS  Google Scholar 

  • Fritsche M, Haessler C, Brandner G (1993) Induction of nuclear accumulation of the tumour suppressor protein p53 by DNA-damaging agents. Oncogene 8:307

    PubMed  CAS  Google Scholar 

  • Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413

    Article  PubMed  CAS  Google Scholar 

  • Gannon JV, Greaves R, Iggo R, Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595

    PubMed  CAS  Google Scholar 

  • Ginsberg AM, Raffeld M, Cossman J (1992) Mutations of the retinoblastoma gene in human lymphoid neoplasms. Leuk Lymphoma 7:359

    Article  PubMed  CAS  Google Scholar 

  • Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B (1993) Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309

    Article  PubMed  CAS  Google Scholar 

  • Gupta RK, Patel K, Bodmer WF, Bodmer JG (1993) Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease. Proc Natl Acad Sci USA 90:2817

    Article  PubMed  CAS  Google Scholar 

  • Halevy O, Hall A, Oren M (1989) Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment. Mol Cell Biol 9:3385

    PubMed  CAS  Google Scholar 

  • Hall PA, McKee PH, Menage HD, Dover R, Lane DP (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203

    PubMed  CAS  Google Scholar 

  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell 75:805

    Article  PubMed  CAS  Google Scholar 

  • Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ (1990) Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells. Cell Growth Diff 1:571

    PubMed  CAS  Google Scholar 

  • Hinds P, Finlay C, Levine AJ (1989) Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 63:739

    PubMed  CAS  Google Scholar 

  • Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakami Y, Hayashi K, Saito H (1992) Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 79:2701

    PubMed  CAS  Google Scholar 

  • Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675

    Article  PubMed  CAS  Google Scholar 

  • Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359:295

    Article  PubMed  CAS  Google Scholar 

  • Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53:16

    PubMed  CAS  Google Scholar 

  • Lane DP and Benchimol S (1990) p53: oncogene or antioncogene. Genes Dev 4:1

    Article  PubMed  CAS  Google Scholar 

  • Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B (1993) p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231

    PubMed  CAS  Google Scholar 

  • Lee EY, To H, Shew J-Y, Brookstein R, Scully P, Lee W-H (1988) Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241:218

    Article  PubMed  CAS  Google Scholar 

  • Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee EY (1987) The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329:642

    Article  PubMed  CAS  Google Scholar 

  • Lee EY, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288

    Article  PubMed  CAS  Google Scholar 

  • Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453

    Article  PubMed  CAS  Google Scholar 

  • Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R (1993) p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289

    PubMed  Google Scholar 

  • Marks JR, Davidoff AM, Kerns B J, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC, Berchuck A (1991) Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51:2979

    PubMed  CAS  Google Scholar 

  • Martinez JC, Piris MA, Sánchez-Beato M, Villuendas R, Orradre JL, Algara P, Sánchez-Verde L, Martínez P (1993) Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. J Pathol 169:405

    Article  PubMed  CAS  Google Scholar 

  • Martinez JC, Mateo M, Sanchez-Beato M, Villuendas R, Orradre JL, Algara P, Sanchez-Verde L, Garcia P, Lopez C, Martinez P, Piris MA (1995) MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression. J Pathol (in press)

    Google Scholar 

  • Mashal R, Shtalrid M, Talpaz M, Kantarjian H, Smith L, Beran M, Cork A, Trujillo J, Gutterman J, Deisseroth A (1990) Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia. Blood 75:180

    PubMed  CAS  Google Scholar 

  • Mateo MS, Sanchez-Beato M, Martinez JC, Orfao A, Orradre JL, Piris MA (1995) p53, bcl2 and Rb expression along the cell cycle. A study in PHA-stimulated lymphocytes and microwave irradiated lymphoid tissue sections. J Clin Pathol 48:151

    Article  PubMed  CAS  Google Scholar 

  • Mihara K, Cao XR, Yen A, Chandler S, Driscoll B, Murphree AL, T’Ang A, Fung YK (1989) Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:1300

    Article  PubMed  CAS  Google Scholar 

  • Moll UM, Riou G, Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262

    Article  PubMed  CAS  Google Scholar 

  • Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The MDM2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237

    Article  PubMed  CAS  Google Scholar 

  • Nakamura H, Said JW, Miller CW, Koeffler HP (1993) Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphoma. Blood 82:920

    PubMed  CAS  Google Scholar 

  • Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705

    Article  PubMed  CAS  Google Scholar 

  • Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80

    Article  PubMed  CAS  Google Scholar 

  • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857

    Article  PubMed  CAS  Google Scholar 

  • Pezzella F, Morrison H, Jones M, Gatter KC, Lane D, Harris AL, Mason DY (1993) Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin’s lymphoma. Histopathol 22:39

    Article  CAS  Google Scholar 

  • Piris MA, Pezzella F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Garrido MC, Gatter K, Aiello A, Delia D, Giardini R, Rilke F (1994) p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br J Cancer 69:337

    Article  PubMed  CAS  Google Scholar 

  • Reid RL, Lindholm PF, Mireskandari A, Dittmer J, Brady JN (1993) Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-1. Oncogene 8:3029

    PubMed  CAS  Google Scholar 

  • Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736

    PubMed  CAS  Google Scholar 

  • Rivas CI, Wisniewski D, Strife A, Perez A, Lambek C, Bruno S, Darzynkiewicz Z, Clarkson B (1992) Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood 79:1982

    PubMed  CAS  Google Scholar 

  • Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP (1990) p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555

    Article  PubMed  CAS  Google Scholar 

  • Rustgi AK, Dyson N, Bernards R (1991) Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352:541

    Article  PubMed  CAS  Google Scholar 

  • Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP (1992) Mutations of the p53 gene in adult T-cell leukemia. Blood 79:477

    PubMed  CAS  Google Scholar 

  • Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeid M (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994

    PubMed  CAS  Google Scholar 

  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howly PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promoted the degradation of p53. Cell 63:1129

    Article  PubMed  CAS  Google Scholar 

  • Sheikh MS, Shao ZM, Hussain A, Fontana JA (1993) The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma. Cancer Res 53:3226

    PubMed  CAS  Google Scholar 

  • Slingerland JM, Minden MD, Benchimol S (1991) Mutation of the p53 gene in human acute myelogenous leukemia. Blood 77:1500

    PubMed  CAS  Google Scholar 

  • Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG (1993) EBNA-5, an Epstein-Barr virus encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 90:5455

    Article  PubMed  CAS  Google Scholar 

  • T’ang A, Varley JM, Chakraborty S, Murphree AL, Fung Y-K (1988) Structural rearrangements of the retinoblastoma gene in human breast carcinoma. Science 242:263

    Article  CAS  Google Scholar 

  • Thor AD, Moore DH, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith H (1992) Accumulation of p53 tumour suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845

    Article  PubMed  CAS  Google Scholar 

  • Trümer LH, Brady G, Bagg A, Gray D, Loke SL, Griesser H, Wagman R, Braziel R, Gascoyne RD, Vicini S, Iscove SS, Cossman J, Mak TW (1993) Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogenity of gene expression and p53 mutations. Blood 81:3097

    Google Scholar 

  • Villuendas R, Piris MA, Algara P, Sanchez-Beato M, Sanchez-Verde L, Martinez JC, Orradre JL, Garcia P, Lopez C, Martinez P (1993) The expression of p53 protein in non-Hodgkin’s lymphoma is not always dependent on p53 gene mutations. Blood 82:3151

    PubMed  CAS  Google Scholar 

  • Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, Martinez JC, Martinez P (1992) p53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol 166:235

    Article  PubMed  CAS  Google Scholar 

  • Whyte P, Buchkovich K, Horowitz JM, Friend SH, Raybuck RA, Weinberg RA, Harlow E (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124

    Article  PubMed  CAS  Google Scholar 

  • Weinberg RA, Harlow E (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124

    Article  PubMed  Google Scholar 

  • Wu X, Bayle JH, Olson D, Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126

    Article  PubMed  CAS  Google Scholar 

  • Xiong P, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701

    Article  PubMed  CAS  Google Scholar 

  • Xu HJ, Hu SX, Benedict WF (1991) Lack of nuclear RB protein staining in G0/middle Gl cells: correlation to changes in total RB protein level. Oncogene 6:1139

    PubMed  CAS  Google Scholar 

  • Yokota J, Akiyama T, Fung Y-K, Benedict WF, Namba Y, Hanaoka M, Wada M, Terasaki T, Shismosato Y, Sugimura T, Terada M (1988) Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3:471

    PubMed  CAS  Google Scholar 

  • Zhang W, Hu G, Estey J, Deisseroth A (1992) Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. Oncogene 7:1645

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Virgen de la Salud Hospital, Toledo, Spain

    Miguel A. Piris, Juan C. Martinez, Margarita Sanchez-Beato, Juan F. Garcia, Carmen Bellas, Javier Menarguez, Raquel Villuendas & Emilia Lloret

  2. Ramon y Cajal Hospital, Madrid, Spain

    Miguel A. Piris, Juan C. Martinez, Margarita Sanchez-Beato, Juan F. Garcia, Carmen Bellas, Javier Menarguez, Raquel Villuendas & Emilia Lloret

  3. Hospital Provincial Gregorio Maranon, Madrid, Spain

    Miguel A. Piris, Juan C. Martinez, Margarita Sanchez-Beato, Juan F. Garcia, Carmen Bellas, Javier Menarguez, Raquel Villuendas & Emilia Lloret

Authors
  1. Miguel A. Piris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan C. Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margarita Sanchez-Beato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Juan F. Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carmen Bellas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Javier Menarguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raquel Villuendas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Emilia Lloret
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Glasgow, Glasgow, Scotland

    Ruth F. Jarrett

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Plenum Press, New York

About this chapter

Cite this chapter

Piris, M.A. et al. (1995). Tumour Suppressor Genes in Hodgkin’s Disease. In: Jarrett, R.F. (eds) Etiology of Hodgkin’s Disease. NATO ASI Series, vol 280. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0339-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0339-8_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-8005-4

  • Online ISBN: 978-1-4613-0339-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation